The association of quality-of-life measures with malignancy and survival in patients with pancreatic pathology

Pancreas

Volumn 40, Issue 7, 2011, Pages 1063-1069

  Velanovich, Vic ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

pancreatic cancer; pancreatic disease; pancreatic surgery; quality of life

Indexed keywords

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; PANCREAS CANCER; PANCREAS DISEASE; PRIORITY JOURNAL; QUALITY OF LIFE; SHORT FORM 36; SOCIAL INTERACTION;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; NEOPLASM STAGING; ODDS RATIO; PANCREATIC DISEASES; PANCREATIC NEOPLASMS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; QUALITY OF LIFE; QUESTIONNAIRES; RISK ASSESSMENT; RISK FACTORS; ROC CURVE; SURVIVAL ANALYSIS; SURVIVAL RATE; TIME FACTORS; YOUNG ADULT;

EID: 80052969280     PISSN: 08853177     EISSN: 15364828     Source Type: Journal    
DOI: 10.1097/MPA.0b013e31821ad8eb     Document Type: Article

References (50)

1. Velanovich V. Using quality-of-life instruments to assess surgical outcomes. Surgery. 1999;126:1-4. (Pubitemid 29340683)
2. Scheingraber S, Scheingraber T, Hirner A. Quality of life in animals as a new outcome for surgical research: G-CSF as a quality of life improving factor. Eur Surg Res. 2002;34:22-29.
3. Troidl H, Kusche J, Vestweber H, et al. Quality of life: An important endpoint both in surgical practice and research. J Chronic Dis. 1987;40:523-528. (Pubitemid 17084798)
4. Peters ML, Sommer M, van Kleef M, et al. Predictors of physical and emotional recovery 6 and 12 months after surgery. Br J Surg. 2010;97:1518-1527.
5. Levine NB, Demonte F. Functional outcome in the neurosurgical patient and its impact on quality of life. Skull Base. 2010;20:19-22.
6. Brattwall H, Stomberg MW, Rawal H, et al. Patient assessed health profile: A six-month quality of life questionnaire after day surgery. Scand J Public Health. 2010;38:574-579.
7. Velanovich V. Using quality-of-life measurements to predict patient satisfaction outcomes for antireflux surgery. Arch Surg. 2004;139:621-626. (Pubitemid 38725070)
8. Nortvedt MW, Riise T, Myhr KM, et al. Quality of life as a predictor for change in disability in MS. Neurology. 2000;55:51-54. (Pubitemid 30460997)
9. Lehto U-S, Ojanen M, Dyba T, et al. Baseline psychosocial predictors of survival in localized breast cancer. Br J Cancer. 2006;94:1245-1252.
10. Gupta D, Granick J, Grutsch JF, et al. The prognostic association of health-related quality of life scores with survival in breast cancer. Support Care Cancer. 2007;15:387-393. (Pubitemid 46697017)
11. Kuchler T, Bestmann B, Rappat S, et al. Impact of psychotherapeutic support for patients with gastrointestinal cancer undergoing surgery: 10-year survival results of a randomized trial. J Clin Oncol. 2007;25:2702-2708. (Pubitemid 47123177)
12. Blazeby JM, Brookes ST, Alderson D. The prognostic value of quality of life scores during treatment for oesophageal cancer. Gut. 2001;49:227-230. (Pubitemid 32675116)
13. Bonnetain F, Paoletti X, Collette S, et al. Quality of life as a prognostic factor of overall survival in patients with advanced hepatocellular carcinoma: Results from two French clinical trials. Qual Life Res. 2008;17:831-843.
14. Fielding R, Wong WS. Quality of life as a predictor of cancer survival among Chinese liver and lung cancer patients. Eur J Cancer. 2007;43:1723-1730. (Pubitemid 47053884)
15. Bottomley A, Coens C, Efficace F, et al. Symptoms and patient-reported well-being: Do they predict survival in malignant pleural mesothelioma? A prognostic factor analysis of EORTC-NCIC 08983: Randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma. J Clin Oncol. 2007;25:5770-5776.
16. Roychowdhury DF, Hayden A, Leipa AM. Health-related quality of life parameters as independent prognostic factors in advanced or metastatic bladder cancer. J Clin Oncol. 2003;21:673-678. (Pubitemid 46621902)
17. Collette L, Van Andel G, Bottomley A, et al. Is baseline quality of life useful for predicting survival with hormone-refractory prostate cancer? A pooled analysis of three studies of the European Organization for Research and Treatment of Cancer Genitourinary Group. J Clin Oncol. 2004;22:3877-3885. (Pubitemid 41079868)
18. Fang FM, Liu YT, Tang Y, et al. Quality of life as a survival predictor for patient with advanced head and neck carcinoma treated with radiotherapy. Cancer. 2004;100:425-432. (Pubitemid 38063655)
19. Mauer MEL, Taphoorn MJB, Bottomley A, et al. Prognostic value of health-related quality-of-life data in predicting survival in patients with anaplastic olgiodendrogliomas, from a phase III EORTC Brain Cancer Group study. J Clin Oncol. 2007;25:5731-5737.
20. Mauer M, Stupp R, Taphoorn MJB, et al. The prognostic value of health-related quality-of-life data in predicting survival in glioblastoma cancer patients: Results from an international randomized phase III EORTC Brain Tumour and Radiation Oncology Groups and NCIC Clinical Trials Group study. Br J Cancer. 2007;97:302-307. (Pubitemid 47196748)
21. Ware JE Jr, Snow KK, Kosinkis M, et al. SF-36 Health Survey: Manual and Interpretation Guide. Boston, MA: The Health Institute, New England Medical Center; 1993.
22. Ware JE Jr, Kosinski M, Keller SD. Physical and Mental Component Summary Scales: A User's Manual. Boston, MA: The Health Institute, New England Medical Center; 1994.
23. Polistina F, Costantin G, Casamassima F, et al. Unresectable locally advanced pancreatic cancer: A multimodal treatment using neoadjuvant chemotherapy (gemcitabine plus stereotactic radiosurgery) and subsequent surgical exploration. Ann Surg Oncol. 2010;17:2092-2101.
24. Robinson DW Jr, Eisenberg DF, Cella D, et al. The prognostic significance of patient-reported outcomes in pancreatic cachexia. J Support Oncol. 2008;6:283-290.
25. Scheingraber S, Scheingraber T, Brauckhoff M, et al. Comparison between a general and a disease-specific health-related quality-of-life questionnaire in patients after pancreatic surgery. J Hepatobiliary Pancreat Surg. 2005;12:290-297. (Pubitemid 41258727)
26. Saquib N, Pierce JP, Saquib J, et al. Poor physical health predicts time to additional breast cancer events and mortality in breast cancer survivors [published online ahead of print]. Psychooncology. 2010.
27. Grande GE, Farquhar MC, Barclay SI, et al. Quality of life measures (EORTC QLQ-30 and SF-36) as predictors of survival in palliative colorectal and lung cancer patients. Palliat Support Care. 2009;7:289-297.
28. van der Waaij LA, van Dullemen HM, Porte RJ. Cyst fluid analysis in the differential diagnosis of pancreatic cystic lesions: A pooled analysis. Gastrointest Endosc. 2005;62:383-389. (Pubitemid 41187940)
29. Tessler DA, Catanzaro A, Velanovich V, et al. Predictors of cancer in patients with suspected pancreatic malignancy without a tissue diagnosis. Am J Surg. 2006;191:191-197. (Pubitemid 43151265)
30. Greer SE, Pipas JM, Sutton JE, et al. Effect of neoadjuvant therapy on local recurrence after resection of pancreatic adenocarinoma. J Am Coll Surg. 2008;206:451-457.
31. Stata Statistical Software: Release 8.0. College Station, TX: Stata Corp; 2003.
32. Velanovich V. Behavior and analysis of the 36-item short-form health survey for surgical quality of life research. Arch Surg. 2007;142:473-478.
33. Hoban A, Velanovich V. Preoperative frailty and quality of life as predictors of postoperative complications. Ann Surg. 2011;253: 1223-1229.
34. Velanovich V, Wollner I. Quality of life and performance status in patients with pancreatic and periampullary tumors. Ann Oncol. 2010;21(suppl 6):vi104.
35. Bell RH Jr. Neoplasms of the exocrine pancreas. In: Bell RH Jr, Rikkers LF, Mulholland MW, eds. Digestive Tract Surgery: A Text and Atlas. Philadelphia,. PA: Lippincott-Raven Publishers; 1996:849-878.
36. Abraham SC, Wilentz RE, Yeo CJ, et al. Pancreaticoduodenectomy (Whipple resection) in patients without malignancy: Are they all "chronic pancreatitis." Am J Surg Pathol. 2003;27:110-120. (Pubitemid 36014904)
37. Spinelli KS, Fromwiller TE, Daniel RA, et al. Cystic pancreatic neoplasms: Observe or operate. Ann Surg. 2004;239:651-657.
38. Lim SJ, Alasadi R, Wayne JD, et al. Preoperative evaluation of pancreatic cystic lesions: Cost-benefit analysis and proposed management algorithm. Surgery. 2005;138:672-680. (Pubitemid 41546189)
39. Walsh RM, Vogt DP, Henderson JM, et al. Natural history of indeterminate pancreatic cysts. Surgery. 2005;138:665-671. (Pubitemid 41546188)
40. Handrich SJ, Hough DM, Fletcher JG, et al. The natural history of the incidentally discovered small simple pancreatic cyst: Long-term follow-up and clinical implications. Am J Roentgenol. 2005;184:20-23. (Pubitemid 40040898)
41. Allen PJ, Jaques DP, D'Angelica M, et al. Cystic lesions of the pancreas: Selection criteria for operative and nonoperative management in 209 patients. J Gastrointest Surg. 2003;7:970-977. (Pubitemid 37524064)
42. Liao T, Velanovich V. Asymptomatic pancreatic cysts: A decision analysis comparing to observation versus resection. Pancreas. 2007;35:243-248. (Pubitemid 47482517)
43. Sheibani-Rad S, Velanovich V. The effects of depression on the survival of pancreatic adenocarcinoma. Pancreas. 2006;32:58-61. (Pubitemid 41803648)
44. Dasgupta M, Rolfson DB, Stolee P, et al. Frailty is associated with postoperative complications in older adults with medical problems. Arch Gerontol Geriatr. 2009;48:78-83.
45. Makary MA, Takenaga RK, Pronovost PJ, et al. Frailty in elderly surgical patients: Implications for operative risk assessment. J Surg Res. 2006;130:212.
46. Christmas C, Makary MA, Burton JR. Medical considerations in older surgical patients. J Am Coll Surg. 2006;203:746-751. (Pubitemid 44648796)
47. Watanabe I, Sasaki S, Konishi M, et al. Onset symptoms and tumor locations as prognostic factors of pancreatic cancers. Pancreas. 2004;28:160-165. (Pubitemid 38269776)
48. Kelsen DP, Portenoy R, Thaler H, et al. Pain as a predictor of outcome in patients with operable pancreatic carcinoma. Surgery. 1997;122:53-59. (Pubitemid 27295167)
49. Crippa S, Dominguez I, Rodriguez JR, et al. Quality of life in pancreatic cancer: Analysis by stage and treatment. J Gastrointest Surg. 2008;12:783-794.
50. Pezzilli R, Campana D, Morselli-Labate AM, et al. Patient reported outcomes in subjects with neuroendocrine tumors of the pancreas. World J Gastroenterol. 2009;15:5067-5073.